Excited to announce our investment alongside Valor Capital in the R$ 45M ($8M) series A of Klivo which provides a chronic disease management platform, starting with diabetes and Brazil. Tau Ventures is an AI-first fund in Silicon Valley investing primarily in seed but we occasionally take later bets when we see immense promise. We are investing in US / Canada but in exceptional cases will consider a deal outside, Klivo being the very first one. The company was founded in 2020 and impressed us with (1) a strong need, (2) building an execution-focused team, and (3) creating a differentiated product…....
Why We Invested In Klivo — Chronic Disease Management Platform
2 min read
Comments are closed.